These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transformation of marginal zone lymphoma (and association with other lymphomas). Casulo C; Friedberg J Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708 [TBL] [Abstract][Full Text] [Related]
12. [Malignant lymphoma. Physiopathology and treatment. 2. Lymphoma of low grade malignancy]. Kobayashi Y Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1581-7. PubMed ID: 18720599 [No Abstract] [Full Text] [Related]
13. Intrafollicular neoplasia/"in situ" lymphoma: a proposal for morphology and immunodiagnostic classification. Carbone A; Gloghini A Am J Hematol; 2011 Aug; 86(8):633-9. PubMed ID: 21674580 [No Abstract] [Full Text] [Related]
14. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. Hamadani M; Benson DM; Lin TS; Porcu P; Blum KA; Devine SM Eur J Haematol; 2008 Dec; 81(6):425-31. PubMed ID: 18774954 [TBL] [Abstract][Full Text] [Related]
15. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma]. Ogura M Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928 [No Abstract] [Full Text] [Related]
16. Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases. Onsun N; Su O; Kural YB; Erdemoglu Y; Buyukbabani N; Demirkesen C; Aydin Y Acta Derm Venereol; 2011 Jun; 91(4):476-8. PubMed ID: 21537819 [No Abstract] [Full Text] [Related]
17. Current management of follicular lymphomas. Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892 [TBL] [Abstract][Full Text] [Related]
18. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells. Bu X; Zheng Z; Wang C; Yu Y Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308 [TBL] [Abstract][Full Text] [Related]
20. Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma. de Vos S; Goy A; Dakhil SR; Saleh MN; McLaughlin P; Belt R; Flowers CR; Knapp M; Hart L; Patel-Donnelly D; Glenn M; Gregory SA; Holladay C; Zhang T; Boral AL J Clin Oncol; 2009 Oct; 27(30):5023-30. PubMed ID: 19770386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]